Opioids: Page 9

FDA expands the opioids covered by risk mitigation strategy
By DrBicuspid.com staff writers
So-called "immediate-release" opioid pain medications will now be subject to more stringent requirements by the U.S. Food and Drug Administration (FDA) to help stem the tide of opioid misuse and abuse, according to a statement from FDA Director Scott Gottlieb, MD.
September 28, 2017
New white paper offers opioid use recommendations
By DrBicuspid.com staff writers
A new white paper from the American Association of Oral and Maxillofacial Surgeons recommends that ibuprofen, not opioids, be used as a first-line therapy for managing a patient's acute and postsurgical pain.
August 28, 2017
Opioid analgesic Opana ER pulled from U.S. market
By DrBicuspid.com staff writers
Endo Pharmaceuticals has announced it will voluntarily remove its opioid analgesic Opana ER from the U.S. market because of a risk for abuse.
July 5, 2017
Second Opinion: Outpatient detoxification for opioid-addicted patients
By Vikram Tarugu, MD
While steps are needed to reduce the number of prescribed opioids in the U.S., what about those patients who may already be addicted and at risk? In this Second Opinion, Vikram Tarugu, MD, details a detoxification program that may be appropriate for your patients and your community.
June 14, 2017
2017 06 14 12 20 15 593 Tarugu Vikram 400
FDA asks drug firm to stop selling opioid analgesic Opana ER
By DrBicuspid.com staff writers
The U.S. Food and Drug Administration (FDA) has requested that Endo Pharmaceuticals stop selling the reformulated version of its opioid analgesic Opana ER due to the risk for abuse.
June 8, 2017
Opioid painkillers more common in low-income households
By Theresa Pablos
Household income may determine whether a patient uses an opioid or nonopioid analgesic for dental pain, a new study has found. Participants from households making less than $15,000 per year were nearly twice as likely to take opioids than those from the highest income bracket.
May 25, 2017
2016 10 06 15 22 02 163 Bottle Pills 400
Trump to nominate opioid commission members
By DrBicuspid.com staff writers
U.S. President Donald Trump has announced his nominations for a national commission to combat opioid addiction.
May 11, 2017
Survey: Patients seek opioid alternatives for postextraction pain
By Tony Edwards
After third-molar extractions, patients and their parents overwhelmingly prefer nonopioid pain management, according to a study presented at the 2017 American College of Oral and Maxillofacial Surgeons annual meeting.
May 7, 2017
2016 10 06 15 22 02 163 Bottle Pills 400
Trump administration to create opioid commission
By DrBicuspid.com staff writers
The Trump administration is forming a national commission to combat opioid addiction.
March 26, 2017
The role of opioid alternatives in oral surgery
By Timothy Gocke, DDS
Postsurgical pain is one of many common fears patients have before undergoing a surgical procedure. Opioids have been the primary prescribed pain medication after dental extractions, but there are too many being prescribed. Dr. Timothy Gocke explores some nonopioid alternatives for pain management, including an injectable option.
February 26, 2017
2016 10 06 15 22 02 163 Bottle Pills 400
NJ dental association creates new opioid guidelines
By DrBicuspid.com staff writers
The New Jersey Dental Association (NJDA) has created new guidelines to help its members safely prescribe and dose opioid medications for acute dental pain.
November 6, 2016
Study: 100M opioids unused annually after oral surgery
By Donna Domino
More than half of opioids prescribed to patients after dental extractions are not taken after surgery, a new study has found. The surplus is troubling given the ongoing opioid epidemic and evidence showing that people who abuse opioids often use leftover pills prescribed for friends or family, University of Pennsylvania researchers said.
October 6, 2016
2016 10 06 15 22 02 163 Bottle Pills 400
Previous Page
Page 9 of 11
Next Page